Cardio Diagnostics Holdings, Inc.CDIO決算レポート
Nasdaq · ヘルスケア · in vitro及びin vivo診断物質
Cardio Diagnostics Holdings, Inc. is a precision cardiovascular healthcare company that develops and commercializes integrated genetic and epigenetic diagnostic tests for early detection of coronary heart disease, heart failure, and other cardiovascular conditions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, focusing on delivering accessible, personalized cardiovascular care solutions.
What changed in Cardio Diagnostics Holdings, Inc.'s 10-K — 2024 vs 2025
No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.